ESC 365 - The impact of the endocannabinoid system on the profibrotic profile of cardiac fibroblasts associated with DMD

HFA Premium Access

The impact of the endocannabinoid system on the profibrotic profile of cardiac fibroblasts associated with DMD

Session: Basic science - cardiac disease 3

Topic: Cardiomyopathies

Speaker: Doctor L. Savchenko (Toulouse, FR)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Lesia Savchenko

Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)

0 follower

6 more presentations in this session

Reversal of age-related diastolic dysfunction in rats by procyanidins and oenothein B with suppression of NOS-NO/ROS imbalance and reduced left ventricular remodeling and fibrosis

Speaker: Ms H. MUZAMMEL (Strasbourg, FR)

Tenascin-C inhibition rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes

Speaker: Ms J. Marksteiner (Vienna, AT)

High-throughput proteomic analysis unveils metabolic and mitochondrial signaling rewiring by chronic ivabradine treatment in duchenne muscular dystrophy

Speaker: Mr C. Dostal (Vienna, AT)

Computational models of cardiac metabolism reveal distinct metabolic phenotypes in dilated cardiomyopathy patients

Speaker: Mr B. Nihant (Maastricht, NL)

MLIP and Junctophilin-1 exhibit atypical phosphosites in diabetic hearts: a novel therapeutic target for diabetic cardiomyopathy?

Speaker: Doctor S. Chacar (Abu Dhabi, AE)

Access the full session

Basic science - cardiac disease 3

Speakers: Doctor L. Savchenko, Ms H. MUZAMMEL, Ms J. Marksteiner, Mr C. Dostal, Mr B. Nihant...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources